Genotype-Phenotype Analysis in HbS-Beta-Thalassemia

Autor: Altay, C., Öner, C., Öner, R., Mesci, L., Balkan, H., Tüzmen, S., Başak, A.N., Gümrük, F., Gürgey, A.

Publikováno v: Human Heredity, 1997 May 01. 47(3), 161-164.

Externí odkaz: https://www.jstor.org/stable/45102867

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.

Autor: Tüzmen Ş; Department of Biological Sciences, Molecular Biology & Genetics Program, Faculty of Arts & Sciences, Eastern Mediterranean University (EMU), Famagusta, North Cyprus via Mersin 10, 99628, Turkey.; Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA., Hostetter G; Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.; Van Andel Research Institute, Grand Rapids, MI 49503, USA., Watanabe A; Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.; Cigna Medical Group, Texas Tech University, Phoenix, AZ, USA., Ekmekçi C; Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.; Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey., Carrigan PE; Cancer Center & Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA.; Bayer HealthCare, Berlin, Germany., Shechter I; Department of Surgery, School of Medicine, Uniformed Services University, Bethesda, MD 20814, USA., Kallioniemi O; Medical Biotechnology Center, VTT Technical Research Centre of Finland & University of Turku, Turku, Finland., Miller LJ; Cancer Center & Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA., Mousses S; Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.; Systems Oncology, Scottsdale, AZ 85260, USA.

Publikováno v: Personalized medicine [Per Med] 2019 Jan; Vol. 16 (1), pp. 51-65. Date of Electronic Publication: 2018 Nov 23.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran.

Autor: Rizk M; Molecular Biology and Genetics Program, Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University (EMU), Famagusta, North Cyprus, Turkey., Tüzmen Ş; Molecular Biology and Genetics Program, Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University (EMU), Famagusta, North Cyprus, Turkey.

Publikováno v: Pharmacogenomics and personalized medicine [Pharmgenomics Pers Med] 2017 Nov 10; Vol. 10, pp. 267-278. Date of Electronic Publication: 2017 Nov 10 (Print Publication: 2017).